Global Blood Screening Market is valued approximately at USD 2.02 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 8.70% over the forecast period 2019-2026. A Blood screening is a medical process in which blood is examined for a specific condition and it helps to monitor disease and a variety of other conditions such any sort of infection or disease. Blood Screening technology is widely used in various fields of diagnostics of diseases such as HIV, Cancer and infections. Additionally, Blood Screening to witness prominent growth owing to the incorporation of nucleic acid amplification test and advancements in blood screening tests. As a result, the demand & adoption for blood screening would increase thereby, making its way for the growth of the market. The growth of the market is primarily driven by the prevalence of infectious diseases and demand for safe blood units. For Instance: According to the LANCET Public Health in 2017, the incidence of HIV has increased from 0.23 per 100,000 in 2004 to approx. 4.2 per 100,000 individuals in 2017. Similarly, as per the SupChina Organization in China, the surge in the number of HIV-infected people increased from 759,000 in 2017 to approx. 1.2 million in 2018. Similarly, as per the National Center for Health Statistics in 2017, around 54,285 new cases of salmonella were reported across United States. As a result, the demand and need for blood screening tests would increase as these tests are widely utilized to observe, screen and assess to analyze human conditions. Furthermore, emergence of multiplexing and microbiology screening are also expected to set various opportunities for the growth of the market. However, high initial set up cost and complex regulations for blood bank and screening test is expected to impede the growth of the market over the forecast period.

The regional analysis of global Blood Screening market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is expected to hold a notable share in the world in terms of revenue owing to the growing prevalence of infectious diseases along with the increasing demand for donated blood. The dominance of the region is witnessed owing to the presence of the well-established infrastructure for hospitals and clinical laboratories and increasing prevalence of newer pathogens. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period. Factors such as rising public-private initiative aimed towards boosting advance research practices and increase investment to promote blood screening research is expected to create lucrative prospects for the growth pf the region during the forecast period of 2019-2026.

Major market player included in this report are:
Grifols S.A
F. Hoffmann-La Rochen AG
Abbott Laboratories
Biom?rieux
Bio-Rad Laboratories Inc.
Becton, Dickson and Company
Danaher Corporation
Ortho Clinical Diagnostics
Siemens Healthineers AG
Thermo Fisher Scientific

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Reagents & Kits
Instruments
Software & Services
By Technology:
Nucleic Acid Testing
ELISA
Rapid Tests
Western Blot Assays
Next Generation Sequencing (NGS)
By End-User:
Blood Banks
Hospitals
By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026

Target Audience of the Global Blood Screening Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors